Discovery of a druggable pocket in SARS-CoV-2 Spike: New avenue to defeat COVID-19?
28 Jul 2020

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Key to SARS-CoV-2 therapeutic development is to unravel the mechanisms driving high infectivity, broad tissue tropism and severe pathology. SARS-CoV-2 is decorated by multiple copies of a glycoprotein, called Spike, which is key to such severe infectivity.

Using cryo-electron microscopy and cloud computing, Genscript has discovered a potentially druggable pocket within the SARS-CoV-2 Spike, which appears to be present in the highly pathogenic coronaviruses that caused previous SARS and MERS outbreaks.

Watch this webinar to find out for the first time the structural link between COVID-19 pathology and the virus itself, setting the stage for developing new therapeutic interventions to combat and defeat COVID-19.

Key learning objectives:

Learn about the high-tech science technologies and techniques being used to defeat the global COVID-19 epidemic.

Who should attend?

  • COVID19 researchers
  • R&D scientists in academia and industry
  • Biologists
  • Biochemists
  • Those working within CROs and CDMOs
  • Drug developers

Certificate of attendance

All webinar participants can request a certificate of attendance, and a learning outcomes summary document for continuing education purposes.